NuScale Power Class Action Reminder
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 13 2026
0mins
Should l Buy SMR?
Source: Globenewswire
- Class Action Notice: Rosen Law Firm reminds investors who purchased NuScale Power Class A common stock between May 13, 2025, and November 6, 2025, to apply to be lead plaintiff by April 20, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that NuScale made false or misleading statements during the class period, failing to disclose ENTRA1 Energy LLC's lack of experience in the nuclear sector, which exposed investors to significant undisclosed risks that could impact the company's commercialization strategy.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked No. 1 by ISS Securities Class Action Services in 2017, demonstrating its strong capabilities and track record in this field.
- Investor Advisory: Investors are advised to carefully select legal counsel, avoiding inexperienced intermediaries, to ensure effective legal support and potential compensation in the class action.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SMR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SMR
Wall Street analysts forecast SMR stock price to rise
13 Analyst Rating
5 Buy
6 Hold
2 Sell
Hold
Current: 10.990
Low
18.50
Averages
32.77
High
60.00
Current: 10.990
Low
18.50
Averages
32.77
High
60.00
About SMR
NuScale Power Corporation is a provider of proprietary advanced small modular reactor nuclear technology. The NuScale Power Module, the Company's SMR technology, is a small pressurized water reactor that can generate 77 megawatts of electricity (MWe) or 250 megawatts thermal (gross) and can be scaled to meet customer needs through an array of flexible configurations of up to 924 MWe (12 modules) of output. In addition to the sale of NPMs, it offers a diversified suite of services throughout the development and operating life of the power plant. The Company's suite of services is planned to include licensing support, testing, training, fuel supply services and program management, among others. It serves a range of customers consisting of governments, political subdivisions, state-owned enterprises, investor-owned utilities and other technology and industrial companies, both in domestic and international markets.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Class Action Notice: Rosen Law Firm reminds investors who purchased NuScale Power Class A common stock between May 13, 2025, and November 6, 2025, to apply as lead plaintiffs by April 20, 2026, to participate in the class action and seek compensation.
- Lawsuit Background: The lawsuit alleges that NuScale made false and misleading statements throughout the class period, failing to disclose ENTRA1 Energy LLC's lack of experience in the nuclear sector, exposing investors to significant risks and potential losses.
- Law Firm's Advantage: Rosen Law Firm specializes in securities class actions and recovered over $438 million for investors in 2019, demonstrating a strong track record in handling such cases, prompting investors to carefully select experienced legal counsel.
- Investor Rights Protection: Until the class action is certified, investors can choose to remain absent or select their own counsel, with their ability to participate in any potential recovery not dependent on serving as lead plaintiffs, ensuring their rights are safeguarded.
See More
- Lawsuit Background: Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action against NuScale Power Corporation on behalf of investors who purchased Class A common stock between May 13, 2025, and November 6, 2025, highlighting serious concerns over the company's financial transparency.
- Financial Crisis: NuScale's general and administrative expenses surged over 3,000% to $519 million in Q3 2025, primarily due to a $495 million payment to ENTRA1, resulting in a quarterly net loss of $532 million, indicating significant mismanagement of company finances.
- Stock Price Plunge: Following the financial disclosures, NuScale's Class A common stock dropped by $5.45, or approximately 14.4%, from $37.91 to $32.46 on November 6, 2025, reflecting market pessimism regarding the company's future prospects.
- Investor Action: Affected investors can seek to be appointed as lead plaintiffs in the class action by April 20, 2026, indicating a growing concern over corporate governance and legal compliance, which may influence future investment decisions.
See More
- Class Action Initiated: NuScale Power Corporation is facing a class action lawsuit for alleged violations of the Securities Exchange Act during the trading period from May 13 to November 6, 2025, with investors having until April 20, 2026, to apply as lead plaintiffs, highlighting significant investor concerns regarding corporate governance and transparency.
- Financial Losses Exposed: The lawsuit alleges that NuScale's general and administrative expenses surged over 3,000% to $519 million in Q3, primarily due to a $495 million payment to ENTRA1, resulting in a quarterly net loss skyrocketing to $532 million, indicating a severe deterioration in the company's financial health.
- Technology Partnership Risks: The global commercialization partnership with ENTRA1 is under scrutiny as ENTRA1 lacks operational experience in the nuclear energy sector, raising investor concerns about the feasibility of NuScale's commercialization strategy and potential delays or regulatory challenges for future projects.
- Stock Price Volatility: Following the financial disclosures on November 6, 2025, NuScale's stock price plummeted over 12% within two days, reflecting a pessimistic market sentiment regarding the company's future prospects and severely undermining investor confidence.
See More
- Lawsuit Background: NuScale Power Corporation (NYSE: SMR) is facing a class action lawsuit for securities fraud, alleging significant misstatements regarding its commercialization strategy for nuclear projects during the period from May 13 to November 6, 2025, with a deadline of April 20, 2026, for investors to seek lead plaintiff status.
- Financial Crisis: On November 6, 2025, NuScale revealed a shocking increase in general and administrative expenses by over 3,000% to $519 million in Q3, resulting in a quarterly net loss of $532 million, a substantial rise from $46 million the previous year, which directly impacted investor confidence and stock performance.
- Stock Price Volatility: Following the financial crisis announcement, NuScale's Class A common stock price dropped by $5.45, or approximately 14.4%, from a closing price of $37.91 on November 5, 2025, to $32.46 on November 6, indicating market concerns about the company's future viability.
- Investor Action: Affected investors are encouraged to contact Kessler Topaz Meltzer & Check, LLP for a free legal consultation, with all representation on a contingency fee basis, aimed at assisting investors in recovering their losses through the ongoing litigation process.
See More
- PayPal Lawsuit Overview: PayPal Holdings, Inc. is facing allegations of overstating its business execution capabilities during the period from February 25, 2025, to February 2, 2026, which may mislead investors about the company's prospects and negatively impact stock prices and investor confidence.
- NuScale Risk Disclosure: NuScale Power Corporation is accused of failing to disclose significant risks associated with its nuclear energy projects during the period from May 13, 2025, to November 6, 2025, potentially exposing its commercialization strategy to failures and regulatory challenges, which could hinder future growth.
- Corcept FDA Concerns: Corcept Therapeutics Incorporated is alleged to have not disclosed FDA concerns regarding the adequacy of its drug effectiveness assessment from October 31, 2024, to December 30, 2025, which may lead to significant obstacles in future drug applications and damage the company's reputation.
- Navan IPO Controversy: Navan, Inc. is accused of failing to disclose a 39% increase in sales and marketing expenses during its 2025 IPO, which could mislead investors about the company's financial health and affect its market performance.
See More
- Lawsuit Background: NuScale Power Corporation is facing a class action lawsuit for securities fraud, primarily accusing its executives of misrepresenting ENTRA1's capabilities, which led to a 12.4% stock drop on November 10, 2025, from $32.46 to $28.43, impacting investor confidence.
- Financial Mismanagement: In Q3 2025, NuScale's general and administrative expenses surged from $17 million to $519 million, largely due to a $495 million payment to ENTRA1 for services, indicating significant financial mismanagement that could affect future investment decisions.
- Market Reaction: Analysts highlighted that ENTRA1, a 3-year-old company, lacks experience in building nuclear projects, leading to a decline in investor trust in NuScale, further exacerbating stock volatility and reflecting market concerns over corporate governance and transparency.
- Legal Implications: Investors must apply by April 20, 2026, to be appointed as lead plaintiffs; if successful, this could pressure NuScale's management to improve governance and transparency to restore market confidence.
See More











